These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 18082099

  • 1. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
    Cortés R, Portolés M, Roselló-Lletí E, Martínez-Dolz L, Almenar L, Salvador A, Rivera M.
    Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099
    [Abstract] [Full Text] [Related]

  • 2. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L, Tatou E, Vergely C, Maupoil V, Bouchot O, Mossiat C, Jazayeri S, Benkhadra S, Brenot R, Girard C, David M.
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [Abstract] [Full Text] [Related]

  • 3. Influence of heart failure on nucleolar organization and protein expression in human hearts.
    Roselló-Lletí E, Rivera M, Cortés R, Azorín I, Sirera R, Martínez-Dolz L, Hove L, Cinca J, Lago F, González-Juanatey JR, Salvador A, Portolés M.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):222-8. PubMed ID: 22244875
    [Abstract] [Full Text] [Related]

  • 4. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V, Matteucci M, Ribezzo M, Di Silvestre D, Brambilla F, Agostini S, Mauri P, Padeletti L, Pingitore A, Delsedime L, Rinaldi M, Recchia FA, Pucci A.
    J Cell Mol Med; 2014 Mar 10; 18(3):396-414. PubMed ID: 24444256
    [Abstract] [Full Text] [Related]

  • 5. Advanced glycation end product accumulation in the cardiomyocytes of heart failure patients with and without diabetes.
    Nożyński J, Zakliczyński M, Konecka-Mrowka D, Zielinska T, Zakliczynska H, Nikiel B, Mlynarczyk-Liszka J, Mrowka A, Zembala-Nozynska E, Pijet M, Rdzanowska K, Lange D, Przybylski R, Zembala M.
    Ann Transplant; 2012 Mar 10; 17(2):53-61. PubMed ID: 22743723
    [Abstract] [Full Text] [Related]

  • 6. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R, Neumann F, Ullrich R, Neumüller J, Podesser BK, Neumann M, Schreiner W.
    Cardiovasc Pathol; 2005 Mar 10; 14(3):135-44. PubMed ID: 15914298
    [Abstract] [Full Text] [Related]

  • 7. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy.
    Abraham D, Hofbauer R, Schäfer R, Blumer R, Paulus P, Miksovsky A, Traxler H, Kocher A, Aharinejad S.
    Circ Res; 2000 Oct 13; 87(8):644-7. PubMed ID: 11029398
    [Abstract] [Full Text] [Related]

  • 8. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart.
    Serneri GG, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A, Janming X, Bertolozzi I, Boddi M, Lisi GF, Sani G, Modesti PA.
    Circ Res; 2000 Mar 03; 86(4):377-85. PubMed ID: 10700441
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A, Bloch W, Antonyan A, Goebel H, Fries JU, Schlensak C, Beyersdorf F, Geissler HJ.
    Lymphology; 2010 Sep 03; 43(3):110-7. PubMed ID: 21226413
    [Abstract] [Full Text] [Related]

  • 10. Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytes.
    Cortés R, Roselló-Lletí E, Rivera M, Martínez-Dolz L, Salvador A, Azorín I, Portolés M.
    Cardiovasc Res; 2010 Feb 01; 85(3):464-72. PubMed ID: 19819881
    [Abstract] [Full Text] [Related]

  • 11. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.
    Liu M, Zhai L, Yang Z, Li S, Liu T, Chen A, Wang L, Li Y, Li R, Li C, Tan M, Chen Z, Qian J.
    Mol Cell Proteomics; 2023 Dec 01; 22(12):100667. PubMed ID: 37852321
    [Abstract] [Full Text] [Related]

  • 12. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy.
    Koumi S, Backer CL, Arentzen CE.
    Circulation; 1995 Jul 15; 92(2):164-74. PubMed ID: 7600647
    [Abstract] [Full Text] [Related]

  • 13. Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.
    Ezzitouny M, Sánchez-Lázaro I, Rivera M, Portolés-Sanz M, Roselló-Lletí E, Gil-Cayuela C, Almenar-Bonet L, López-Vilella R, Ferré-Vallverdú M, Sanz-Sánchez J, Cerveró-Rubio A, Jiménez-Aguilella JJ, Pérez-Roselló V, Donoso-Trenado V, Arenas-Martín P, Lozano-Edo S, Jover-Pastor P, Martínez-Dolz L.
    Transplant Proc; 2019 Mar 15; 51(2):369-371. PubMed ID: 30879543
    [Abstract] [Full Text] [Related]

  • 14. Indexes of Angiogenic Activation in Myocardial Samples of Patients with Advanced Chronic Heart Failure.
    Komici K, Gnemmi I, Sangiorgi C, Ricciardolo FLM, Rinaldi M, Di Stefano A, Eleuteri E.
    Medicina (Kaunas); 2019 Nov 29; 55(12):. PubMed ID: 31795484
    [Abstract] [Full Text] [Related]

  • 15. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
    Lee S, Lu R, Müller-Ehmsen J, Schwinger RH, Brixius K.
    Clin Exp Pharmacol Physiol; 2010 Dec 29; 37(12):1134-8. PubMed ID: 20804510
    [Abstract] [Full Text] [Related]

  • 16. Enhanced bioactive myocardial transforming growth factor-β in advanced human heart failure.
    Khan S, Joyce J, Margulies KB, Tsuda T.
    Circ J; 2014 Dec 29; 78(11):2711-8. PubMed ID: 25298166
    [Abstract] [Full Text] [Related]

  • 17. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
    Sweet ME, Cocciolo A, Slavov D, Jones KL, Sweet JR, Graw SL, Reece TB, Ambardekar AV, Bristow MR, Mestroni L, Taylor MRG.
    BMC Genomics; 2018 Nov 12; 19(1):812. PubMed ID: 30419824
    [Abstract] [Full Text] [Related]

  • 18. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ, Shen WK, Rea RF, Friedman PA, Hayes DL, Wokhlu A, Webster TL, Wiste HJ, Hodge DO, Bradley DJ, Hammill SC, Packer DL, Cha YM.
    Heart Rhythm; 2011 Mar 12; 8(3):377-82. PubMed ID: 21070886
    [Abstract] [Full Text] [Related]

  • 19. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, Kandolf R, Schultheiss HP, Kroemer HK, Völker U, Felix SB.
    Am Heart J; 2008 Jul 12; 156(1):92-99.e2. PubMed ID: 18585502
    [Abstract] [Full Text] [Related]

  • 20. Impact of cardiac transplantation on molecular pathology of ET-1, VEGF-C, and mitochondrial metabolism and morphology in dilated versus ischemic cardiomyopathic patients.
    Aharinejad S, Schäfer R, Hofbauer R, Abraham D, Blumer R, Miksovsky A, Traxler H, Pullirsch D, Alexandrowicz R, Taghavi S, Kocher A, Laufer G.
    Transplantation; 2001 Sep 27; 72(6):1043-9. PubMed ID: 11579298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.